Clinical study using denderitic cell vaccinations for cancer patients
Not Applicable
- Conditions
- Malignancy
- Registration Number
- JPRN-UMIN000003255
- Lead Sponsor
- Matsumoto Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
1) Pregnant or lactating women 2) ≥100 IU/l ALT or AST before the start of therapy 3) <50,000 platelet count 4) Allergy to penicillin or picibanil 5) Patients judged ineligible for the therapy by an attending physician 6) Juveniles 7) Adults with impaired judgment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method